[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 15, 1971

Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer

Author Affiliations

From the Department of Research and Statistics, Health Insurance Plan of Greater New York (Mr. Shapiro); Mt. Sinai School of Medicine and Department of Radiology, LaGuardia Hospital (Dr. Strax); and New York Medical College and Beth Israel Medical Center (Dr. Venet), New York.

JAMA. 1971;215(11):1777-1785. doi:10.1001/jama.1971.03180240027005

First results in a long-term investigation to determine whether periodic breast cancer screening with mammography and clinical examination leads to lowered breast cancer mortality provide grounds for cautious optimism. The study compares the experience in a random sample of 31,000 women, aged 40 to 64 years, offered screening examinations with the experience in a similarly constituted "control" group. There were 52 deaths due to breast cancer in the control group, as compared with 31 breast cancer deaths in the study group, in the period available for follow-up. The 3 1/2-year case fatality rates among women with histologically confirmed breast cancers reinforce the impression that screening leads to lowered mortality. More time, possibly ten years of follow-up, is needed to establish whether the effect of the screening program is short-term or long-term.